Thermoresponsive fluconazole gels for topical delivery: rheological and mechanical properties, in vitro drug release and anti-fungal efficacy

References

• Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008;51:2–15
   PubMed Web of Science ®Google Scholar
• Aly R, Berger T. Common superficial fungal infections in patients with AIDS. Clin Infect Dis 1996;22:S128–S32
   PubMed Web of Science ®Google Scholar
• Virgili A, Zampino MR, Mantovani L. Fungal skin infections in organ transplant recipients. Am J Clin Dermatol 2002;3:19–35
   PubMedGoogle Scholar
• Borgers M, Degreef H, Cauwenbergh G. Fungal infections of the skin: infection process and antimycotic therapy. Curr Drug Targets 2005;6:849–862
   PubMed Web of Science ®Google Scholar
• Goa KL, Barradell LB. Fluconazole. An update of its pharmacodynamic and pharmacokinetic properties and therapeutic use in major superficial and systemic mycoses in immunocompromised patients. Drugs 1995;50:658–690
   PubMed Web of Science ®Google Scholar
• Kaur IP, Kakkar S. Topical delivery of antifungal agents. Expert Opin Drug Deliv 2010;7:1303–1327
   PubMed Web of Science ®Google Scholar
• FDA Approved Drug Products database: Drugs@FDA (fluconazole) [database on the Internet]. U.S. Food and Drug Administration. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm [last accessed 5 March 2013]
   Google Scholar
• Assessment report pursuant to Article 30 of Directive 2001/83/EC, as amended. Diflucan and associated names. Report No.: EMA/888361/2011. European Medicines Agency (EMEA), 2 September 2011
   Google Scholar
• Pulat M, Asil D. Fluconazole release through semi-interpenetrating polymer network hydrogels based on chitosan, acrylic acid, and citraconic acid. J Appl Polym Sci 2009;113:2613–2619
   Web of Science ®Google Scholar
• Amichai B, Grunwald MH. Adverse drug reactions of the new oral antifungal agents – terbinafine, fluconazole, and itraconazole. Int J Dermatol 1998;37:410–415
   PubMed Web of Science ®Google Scholar
• Moreira TS, de Sousa VP, Pierre MB. Influence of oleic acid on the rheology and in vitro release of lumiracoxib from poloxamer gels. J Pharm Pharm Sci 2010;13:286–302
   PubMed Web of Science ®Google Scholar
• Chang JY, Oh YK, Choi HG, et al. Rheological evaluation of thermosensitive and mucoadhesive vaginal gels in physiological conditions. Int J Pharm 2002;241:155–163
   PubMed Web of Science ®Google Scholar
• Escobar-Chavez JJ, Lopez-Cervantes M, Naik A, et al. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J Pharm Pharm Sci 2006;9:339–358
   PubMed Web of Science ®Google Scholar
• Juhasz J, Lenaerts V, Raymond P, Ong H. Diffusion of rat atrial natriuretic factor in thermoreversible poloxamer gels. Biomaterials 1989;10:265–268
   PubMed Web of Science ®Google Scholar
• Baloglu E, Karavana SY, Senyigit ZA, et al. In-situ gel formulations of econazole nitrate: preparation and in-vitro and in-vivo evaluation. J Pharm Pharmacol 2011;63:1274–1282
   PubMed Web of Science ®Google Scholar
• Koffi AA, Agnely F, Ponchel G, Grossiord JL. Modulation of the rheological and mucoadhesive properties of thermosensitive poloxamer-based hydrogels intended for the rectal administration of quinine. Eur J Pharm Sci 2006;27:328–335
   PubMed Web of Science ®Google Scholar
• Gratieri T, Gelfuso GM, Rocha EM, et al. A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm 2010;75:186–193
   PubMed Web of Science ®Google Scholar
• Ayub AC, Gomes AD, Lima MV, et al. Topical delivery of fluconazole: in vitro skin penetration and permeation using emulsions as dosage forms. Drug Dev Ind Pharm 2007;33:273–280
   PubMed Web of Science ®Google Scholar
• Salerno C, Carlucci A, Bregni C. Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms. AAPS PharmSciTech 2010;11:986–993
   PubMed Web of Science ®Google Scholar
• Ellaithy H, El-Shaboury K. The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS PharmSciTech 2002;3:77–85
   Google Scholar
• Al-Rimawi F. Development and validation of analytical method for fluconazole and fluconazole related compounds (A, B, and C) in capsule formulations by HPLC with UV detection. Jordan J Chem 2009;4:357–365
   Google Scholar
• Bonferoni MC, Rossi S, Ferrari F, Caramella C. A modified Franz diffusion cell for simultaneous assessment of drug release and washability of mucoadhesive gels. Pharm Dev Technol 1999;4:45–53
   PubMed Web of Science ®Google Scholar
• Vlachou MD, Rekkas DM, Dallas PP, Choulis NH. Development and in vitro evaluation of griseofulvin gels using Franz diffusion cells. Int J Pharm 1992;82:47–52
   Google Scholar
• Chiang CM, Flynn GL, Weiner ND, Szpunar GJ. Bioavailability assessment of topical delivery systems: effect of vehicle evaporation upon in vitro delivery of minoxidil from solution formulations. Int J Pharm 1989;55:229–236
   Google Scholar
• USP35. United States Pharmacopeia and National Formulary (USP 35-NF 30). Rockville (MD): United States Pharmacopeia Convention; 2012
   Google Scholar
• Baboota S, Shakeel F, Ahuja A, et al. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib. Acta Pharm 2007;57:315–332
   PubMedGoogle Scholar
• Escobar-Chávez JJ, Quintanar-Guerrero D, Ganem-Quintanar A. In vivo skin permeation of sodium naproxen formulated in pluronic F-127 gels: effect of Azone® and Transcutol®. Drug Dev Ind Pharm 2005;31:447–454
   PubMed Web of Science ®Google Scholar
• Mura P, Faucci M, Bramanti G, Corti P. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci 2000;9:365–372
   PubMed Web of Science ®Google Scholar
• Lee T-W, Kim J-C, Hwang S-J. Hydrogel patches containing Triclosan for acne treatment. Eur J Pharm Biopharm 2003;56:407–412
   PubMed Web of Science ®Google Scholar
• Godwin DA, Kim N-H, Felton LA. Influence of Transcutol® CG on the skin accumulation and transdermal permeation of ultraviolet absorbers. Eur J Pharm Biopharm 2002;53:23–27
   PubMed Web of Science ®Google Scholar
• Jones DS, Bruschi ML, de Freitas O, et al. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity. Int J Pharm 2009;372:49–58
   PubMed Web of Science ®Google Scholar
• FDA Inactive Ingredient Search for Approved Drug Products: Diethylene glycol monoethyl ether [database on the Internet]. U.S. Food and Drug Administration. Available from: http://www.accessdata.fda.gov/scripts/cder/iig/index.cfm [last accessed 5 August 2013]
   Google Scholar
• Cho H-J, Balakrishnan P, Park E-K, et al. Poloxamer/cyclodextrin/chitosan-based thermoreversible gel for intranasal delivery of fexofenadine hydrochloride. J Pharm Sci 2011;100:681–691
   PubMed Web of Science ®Google Scholar
• Dumortier G, Grossiord J, Agnely F, Chaumeil J. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006;23:2709–2728
   PubMed Web of Science ®Google Scholar
• Armstrong J, Chowdhry B, Mitchell J, et al. Effect of cosolvents and cosolutes upon aggregation transitions in aqueous solutions of the poloxamer F87 (Poloxamer p237): a high sensitivity differential scanning calorimetry study. J Phys Chem 1996;100:1738–1745
   Web of Science ®Google Scholar
• Hagerstrom H, Paulsson M, Edsman K. Evaluation of mucoadhesion for two polyelectrolyte gels in simulated physiological conditions using a rheological method. Eur J Pharm Sci 2000;9:301–309
   PubMed Web of Science ®Google Scholar
• Baloglu E, Karavana SY, Senyigit ZA, Guneri T. Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base. Pharm Dev Technol 2011;16:627–636
   PubMed Web of Science ®Google Scholar
• Jones DS, Woolfson AD, Brown AF. Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm 1997;151:223–233
   Web of Science ®Google Scholar
• Jones DS, Woolfson AD, Djokic J, Coulter WA. Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharm Res 1996;13:1734–1738
   PubMed Web of Science ®Google Scholar
• Tas C, Ozkan Y, Savaser A, Baykara T. In vitro release studies of chlorpheniramine maleate from gels prepared by different cellulose derivatives. Farmaco 2003;58:605–611
   PubMedGoogle Scholar
• Zhang L, Parsons DL, Navarre C, Kompella UB. Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur. J Control Release 2002;85:73–81
   PubMed Web of Science ®Google Scholar
• Gilbert JC, Hadgraft J, Bye A, Brookes LG. Drug release from pluronic F-127 gels. Int J Pharm 1986;32:223–228
   Web of Science ®Google Scholar
• Bentley M, Marchetti JM, Ricardo N, et al. Influence of lecithin on some physical chemical properties of poloxamer gels: rheological, microscopic and in vitro permeation studies. Int J Pharm 1999;193:49–55
   PubMed Web of Science ®Google Scholar
• Ricci EJ, Bentley MVLB, Farah M, et al. Rheological characterization of poloxamer 407 lidocaine hydrochloride gels. Eur J Pharm Sci 2002;17:161–167
   PubMed Web of Science ®Google Scholar
• Edsman K, Carlfors J, Petersson R. Rheological evaluation of Poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci 1998;6:105–112
   PubMed Web of Science ®Google Scholar
• Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006;23:2709–2728
   PubMed Web of Science ®Google Scholar
• Barry AL, Brown SD. Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J Clin Microbiol 1996;34:2154–2157
   PubMed Web of Science ®Google Scholar
• CLSI. Method for antifungal disk diffusion susceptibility testing of yeasts; approved guideline – Second Edition. CLSI document M44-A2. Wayne (PA): Clinical and Laboratory Standards Institute; 2009
   Google Scholar
• Gupta A, Dlova N, Taborda P, et al. Once weekly fluconazole is effective in children in the treatment of tinea capitis: a prospective, multicentre study. Br J Dermatol 2000;142:965–968
   Google Scholar
• Pulat M, Eksi H, Abbasoglu U. Fluconazole release from hydrogels including acrylamide-acrylic acid-itaconic acid, and their microbiological interactions. J Biomat Sci Polym Ed 2008;19:193–205
   Web of Science ®Google Scholar